Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle Le

Showing results (121-130 of 124) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 124 results.
Annals of the Rheumatic Diseases|February 28, 2019
PTPN14 phosphatase and YAP promote TGFβ signalling in rheumatoid synoviocytesAngel Bottini, Dennis J Wu, Rizi Ai, et al.
Lancet (London, England)|August 8, 2006
CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trialJintanat Ananworanich, Angèle Gayet-Ageron, Michelle Le Braz, et al.
Molecular Cell|July 21, 2021
Lysine acetylation restricts mutant IDH2 activity to optimize transformation in AML cellsDong Chen, Siyuan Xia, Rukang Zhang, et al.
JAMA|April 21, 2011
Identification of a novel TP53 cancer susceptibility mutation through whole-genome sequencing of a patient with therapy-related AMLDaniel C Link, Laura G Schuettpelz, Dong Shen, et al.
Pageof 13

Showing results (121-130 of 124) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 124 results.
Annals of the Rheumatic Diseases|February 28, 2019
PTPN14 phosphatase and YAP promote TGFβ signalling in rheumatoid synoviocytesAngel Bottini, Dennis J Wu, Rizi Ai, et al.
Lancet (London, England)|August 8, 2006
CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trialJintanat Ananworanich, Angèle Gayet-Ageron, Michelle Le Braz, et al.
Molecular Cell|July 21, 2021
Lysine acetylation restricts mutant IDH2 activity to optimize transformation in AML cellsDong Chen, Siyuan Xia, Rukang Zhang, et al.
JAMA|April 21, 2011
Identification of a novel TP53 cancer susceptibility mutation through whole-genome sequencing of a patient with therapy-related AMLDaniel C Link, Laura G Schuettpelz, Dong Shen, et al.
Pageof 13